Astrana Health's Earnings Growth Potential Through RAF Score Enhancement: A Buy Rating Analysis
Analysts Conflicted on These Healthcare Names: Quest Diagnostics (DGX), Astrana Health (ASTH) and Dexcom (DXCM)
Astrana Health, Inc. to Participate in Upcoming Investor Conferences
Astrana Health (NASDAQ:ASTH) Could Be Struggling To Allocate Capital
Astrana Health's (NASDAQ:ASTH) Strong Earnings Are Of Good Quality
Baird Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $67
Express News | Baird Maintains Outperform on Astrana Health, Raises Price Target to $67
Astrana Health and Awell Forge Partnership to Bring CareOps to Value-Based Healthcare
Astrana Health | 10-Q: Q2 2024 Earnings Report
Astrana Health Is Maintained at Buy by Truist Securities
Astrana Health Price Target Raised to $59.00/Share From $50.00 by Truist Securities
Astrana Health Second Quarter 2024 Earnings: Beats Expectations
Express News | Astrana Health Inc : Truist Securities Raises Target Price to $59 From $50
Truist Securities Raises Price Target on Astrana Health to $59 From $50, Maintains Buy Rating
Astrana Health's Strong Q2 Performance and Strategic Growth Fuel Buy Rating
Does Astrana Health (ASTH) Have a Long Runway for Growth?
Astana Health, Inc. (ASTH) Q2 2024 Earnings Call Transcript
Astrana Health Sees FY24 EPS $1.12-$1.36 Vs $1.42 Est.; Revenue $1.75B-$1.85B Vs $1.76B Est.
Express News | Apollo Medical Holdings Inc FY2024 Shr View $1.42, Rev View $1.76 Bln -- LSEG IBES Data
Express News | Astrana Health, Inc. : Sees FY EPS $1.12-$1.36
No Data